02:29 PM EDT, 08/12/2024 (MT Newswires) -- Eli Lilly ( LLY ) on Monday filed a prospectus to raise debt for the $3.2 billion acquisition of Morphic.

The pharma company is looking to issue five separate series of notes to raise the funds, according to the securities filing.

The company is yet to price the notes, but Bloomberg reported the company is looking to raise $5 billion.

Amounts left after the Morphic acquisition will be used to repay the company's outstanding commercial paper, Lilly said in its securities filing.

The longest portion of the deal could reportedly be a 40-year note that would offer a yield of 1.3% point over Treasuries, according to Bloomberg, citing a person with knowledge of the matter.

Eli Lilly ( LLY ) did not immediately respond to a request for comment from MT Newswires.

Price: 891.28, Change: -0.40, Percent Change: -0.04